Linde Gas & Equipment Inc.

Form 483 issued April 1, 2026

Inspection
Mar 27 – Apr 1, 2026
Investigator
Luxuly Abraham
Observations
2
Pages
2
FEI number
2523408

In short: On April 1, 2026, FDA issued a Form 483 with 2 observations to Linde Gas & Equipment Inc. (FEI 2523408) after an inspection that ran Mar 27 – Apr 1, 2026. The investigator was Luxuly Abraham. Most observations concern quality system and laboratory controls; the most-cited regulation is 21 CFR 211.180 (general requirements).

At a glance

Quality system and laboratory controls account for 2 of 2 observations.

Quality system1
Laboratory controls1

Most cited: 21 CFR 211.180 (1×) · 211.166 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    The firm failed to conduct thorough and…

  2. 02

    There is no written testing program designed to assess the stability characteristic of USP grade Air…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Linde Gas & Equipment Inc.?

FDA listed 2 observations on this Form 483, mostly about quality system and laboratory controls. The most-cited regulation is 21 CFR 211.180 (general requirements). The opening words of each observation are shown on this page.

Who inspected Linde Gas & Equipment Inc.?

Luxuly Abraham is named on this Form 483, for the inspection of Mar 27 – Apr 1, 2026. Each investigator has a profile showing what they cite most.

When was Linde Gas & Equipment Inc. inspected by FDA?

The inspection ran Mar 27 – Apr 1, 2026, and the Form 483 is dated April 1, 2026.

How do I get the full Form 483 for Linde Gas & Equipment Inc.?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free